BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29324392)

  • 1. Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing.
    Banaszak LG; Giudice V; Zhao X; Wu Z; Gao S; Hosokawa K; Keyvanfar K; Townsley DM; Gutierrez-Rodrigues F; Fernandez Ibanez MDP; Kajigaya S; Young NS
    Blood Cells Mol Dis; 2018 Mar; 69():10-22. PubMed ID: 29324392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs.
    Yang L; Liu Y; Zhang N; Ding X; Zhang W; Shen K; Huang L; Zhou J; Cui S; Zhu Z; Hu Z; Xiao M
    Oncotarget; 2017 May; 8(18):30395-30409. PubMed ID: 28418922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells.
    Bera R; Chiu MC; Huang YJ; Liang DC; Lee YS; Shih LY
    Neoplasia; 2018 Nov; 20(11):1106-1120. PubMed ID: 30245403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
    Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
    Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic differentiation persists in human iPSCs defective in de novo DNA methylation.
    Cypris O; Franzen J; Frobel J; Glück P; Kuo CC; Schmitz S; Nüchtern S; Zenke M; Wagner W
    BMC Biol; 2022 Jun; 20(1):141. PubMed ID: 35705990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain-of-function mutations in DNMT3A in patients with paraganglioma.
    Remacha L; Currás-Freixes M; Torres-Ruiz R; Schiavi F; Torres-Pérez R; Calsina B; Letón R; Comino-Méndez I; Roldán-Romero JM; Montero-Conde C; Santos M; Pérez LI; Pita G; Alonso MR; Honrado E; Pedrinaci S; Crespo-Facorro B; Percesepe A; Falcioni M; Rodríguez-Perales S; Korpershoek E; Ramón-Maiques S; Opocher G; Rodríguez-Antona C; Robledo M; Cascón A
    Genet Med; 2018 Dec; 20(12):1644-1651. PubMed ID: 29740169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
    Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-mediated gene knockout for DNA methyltransferase Dnmt3a in CHO cells displays enhanced transgenic expression and long-term stability.
    Jia YL; Guo X; Lu JT; Wang XY; Qiu LL; Wang TY
    J Cell Mol Med; 2018 Sep; 22(9):4106-4116. PubMed ID: 29851281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation.
    Bhogal B; Weir BA; Crescenzo R; Marien A; Kwon MC; Philippar U; Cowley GS
    Commun Biol; 2022 Nov; 5(1):1174. PubMed ID: 36329185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development.
    Lu R; Wang P; Parton T; Zhou Y; Chrysovergis K; Rockowitz S; Chen WY; Abdel-Wahab O; Wade PA; Zheng D; Wang GG
    Cancer Cell; 2016 Jul; 30(1):92-107. PubMed ID: 27344947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Analysis of DNMT3A DNA Methyltransferase Mutations Reported in Patients with Acute Myeloid Leukemia.
    Khrabrova DA; Loiko AG; Tolkacheva AA; Cherepanova NA; Zvereva MI; Kirsanova OV; Gromova ES
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31861499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells.
    Ramabadran R; Wang JH; Reyes JM; Guzman AG; Gupta S; Rosas C; Brunetti L; Gundry MC; Tovy A; Long H; Gu T; Cullen SM; Tyagi S; Rux D; Kim JJ; Kornblau SM; Kyba M; Stossi F; Rau RE; Takahashi K; Westbrook TF; Goodell MA
    Nat Cell Biol; 2023 Apr; 25(4):528-539. PubMed ID: 37024683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activity.
    Nguyen TV; Yao S; Wang Y; Rolfe A; Selvaraj A; Darman R; Ke J; Warmuth M; Smith PG; Larsen NA; Yu L; Zhu P; Fekkes P; Vaillancourt FH; Bolduc DM
    J Biol Chem; 2019 Nov; 294(45):16966-16977. PubMed ID: 31582562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologico-clinical significance of DNMT3A variants expression in acute myeloid leukemia.
    Lin N; Fu W; Zhao C; Li B; Yan X; Li Y
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):270-277. PubMed ID: 29024628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming.
    Yang X; Wang X; Yang Y; Li Z; Chen Y; Shang S; Wang Y
    J Transl Med; 2023 Jul; 21(1):481. PubMed ID: 37464424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.
    Cole CB; Russler-Germain DA; Ketkar S; Verdoni AM; Smith AM; Bangert CV; Helton NM; Guo M; Klco JM; O'Laughlin S; Fronick C; Fulton R; Chang GS; Petti AA; Miller CA; Ley TJ
    J Clin Invest; 2017 Oct; 127(10):3657-3674. PubMed ID: 28872462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
    Shi X; Yang Y; Shang S; Wu S; Zhang W; Peng L; Huang T; Zhang R; Ren R; Mi J; Wang Y
    BMC Cancer; 2019 Nov; 19(1):1072. PubMed ID: 31703632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional role of DNMT3A mutation in acute myeloid leukemia].
    Koya J; Kurokawa M
    Rinsho Ketsueki; 2018; 59(5):602-610. PubMed ID: 29877252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional knockin of Dnmt3a R878H initiates acute myeloid leukemia with mTOR pathway involvement.
    Dai YJ; Wang YY; Huang JY; Xia L; Shi XD; Xu J; Lu J; Su XB; Yang Y; Zhang WN; Wang PP; Wu SF; Huang T; Mi JQ; Han ZG; Chen Z; Chen SJ
    Proc Natl Acad Sci U S A; 2017 May; 114(20):5237-5242. PubMed ID: 28461508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.